← Back to Patent Explorer
US5296026A Expired / Lapsed US ⏱️ 0.0 years remaining

Phosphate glass cement

Assignee: Individual
•
Filing: 1988-12-02
•
Granted: 1994-03-22
•
Expires: 2008-12-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are useful and unique glass phosphate cement compositions and methods for their use as surgical implant materials to fill cavities in bone and canals in teeth. The cement compositions consist of glass powders having a range of chemicals including P 2 O 5 , CaO, SrO and Na 2 O in combination with an aqueous liquid and with or without therapeutic agents. Mixing the powder and liquid results in a hardening reaction. When the cement is implanted into hard tissue, it serves as a filler/graft material and along with the release of leachable constituents it can assist in the healing and maintenance of healthy bone.

Inventors

  • 👤 Eugene A. Monroe
  • 👤 Wei-Shi Chen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:33
CPC Classifications
C; C03; C03C; C03C3/00; C03C3/12; C03C3/16; A; A61; A61C; A61C8/00; A61C8/0012; C03C12/00

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 66 words
A cement system consisting of an aqueous liquid and a phosphate glass powder which is reacted by mixing the liquid and powder together in the ratio of 1.5 to 3.0 grams per milliliter to yield a hardened cement composed of 1) any remnant unreacted glass powder and 2) a reaction product called the cementing binder which fills voids between and adhers to any remnant glass powder.
Claim 2
Dependent Claim 66 words
A cement system consisting of an aqueous liquid and a phosphate glass powder which is reacted by mixing the liquid and powder together in the ratio of 1.5 to 3.0 grams per milliliter to yield a hardened cement composed of 1) any remnant unreacted glass powder and 2) a reaction product called the cementing binder which fills voids between and adhers to any remnant glass powder.
Claim 3
Dependent Claim 95 words
The cement of claim 1 wherein the said glass powder for making the cement ranges in chemical composition from 30-60 mol % P 2 O 5 , 20-58 mol % CaO, 0-35 mol % SrO, and 0-30 mol % Na 2 O, with or without one or more of the modifying compounds selected from the group consisting of NaF, CaF 2 , Al 2 O 3 , ZnO, MgCO 3 , B 2 O 3 , NO 3 , K 2 O, and Li 2 O, each in amounts ranging up to 15 mol %.
Claim 4
Dependent Claim 35 words
The cement of claim 1 wherein the aqueous liquid that reacts with the glass powder is water or water plus the addition of phosphoric acid which is conducive to the formation of a surgical cement.
Claim 5
Dependent Claim 45 words
The cement of claim 1 wherein the cement can be implanted into bony cavities and defects and into tooth canals, after mixing the powder component and the liquid component together and while still in the unhardened paste state or after the hardening of the cement.
Claim 6
Dependent Claim 42 words
The cement of claim 1 wherein the powder and liquid components can be reacted together and while still in a paste consistency can be used as a grouting, filling, plastering, grafting or cementing material for medical, dental, veterinarian or non-health related applications.
Claim 7
Dependent Claim 27 words
The cement of claim 1 wherein the cement is formed into hardened pellets, granules, cakes, or other forms for use as a mineral nutrient for living organisms.
Claim 8
Dependent Claim 26 words
The cement of claim 1 wherein the hardened surgically implanted cement is soluble, leachable and degradable, providing a chemical environment conducive to bone healing and development.
Claim 9
Dependent Claim 68 words
The cement of claim 1 wherein the glass powder contains glass plus one or more enhancing agents of: 1) Ca(OH) 2 powder for enhancing the chemical reaction of the cement; and 2) one or more substances selected from the group consisting of autogenous bone fragments, calcium phosphate compounds, and pharmaceutical agents including antibiotics and bone growth stimulators for enhancing the efficacious behavior of the cement after surgical implantation.

References Cited (Backward Citations)

US2450952A Cited
US3510322A Cited
US3873327A Cited
US4135935A Cited
US3913229A Cited
US4123416A Cited
US4149894A Cited
US4097935A Cited
DE2827635A1 Cited
US4308064A Cited
GB2041954A Cited
US4518430A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-03-21 1997-09-20 1998-03-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-03-21 2001-09-20 2002-03-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-03-21 2005-09-20 2006-03-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag